2024
A retrospective cohort study describing chemotherapy-induced peripheral neuropathy in Non-Hodgkin lymphoma patients treated with EPOCH ± R: does HIV status matter?
McNally G, Aossey C, Wiczer T, Sinnott L, Lustberg M, Baiocchi R, Lustberg M. A retrospective cohort study describing chemotherapy-induced peripheral neuropathy in Non-Hodgkin lymphoma patients treated with EPOCH ± R: does HIV status matter? Leukemia & Lymphoma 2024, 65: 1110-1116. PMID: 38648546, DOI: 10.1080/10428194.2024.2340051.Peer-Reviewed Original ResearchChemotherapy-induced peripheral neuropathyIncidence of chemotherapy-induced peripheral neuropathyHIV statusPeripheral neuropathyHIV-associated non-Hodgkin's lymphomaCohort studyDose-adjusted EPOCHNon-Hodgkin's lymphomaLong-term patient outcomesRetrospective cohort studyNon-HodgkinComprehensive cancer centerCancer CenterHIVPatientsNeuropathyPatient outcomesPropensity scoreLymphomaAdverse effectsIncidenceStatusRegimenVincristine
2023
Biomechanical Effect of Music and Dance on Postural Control Among Breast Cancer Survivors With Neuropathy
Worthen-Chaudhari L, Bland C, WIlder J, Wali R, Bibi A, Taha S, Costa-GIomi E, Crasta J, Schnell P, Hackney M, Lustberg M. Biomechanical Effect of Music and Dance on Postural Control Among Breast Cancer Survivors With Neuropathy. Archives Of Physical Medicine And Rehabilitation 2023, 104: e14-e15. DOI: 10.1016/j.apmr.2022.12.039.Peer-Reviewed Original ResearchDance trainingEffects of musicBreast cancer survivorsMusic trainingMusicCancer survivorsIntervention pilotDancePostural swayOncology outpatientsBC survivorsIntervention periodPostural controlMovementNeuromotor controlPressure measuresNeuropathyBalance deficitsSurvivorsBiomechanical effectsPositive effect sizesEffect sizeSwayWeeksTrainingCase Study in Chemotherapy-Induced Neuropathy: Tango Dance Improved Over-Ground Local Gait Stability
Glover N, WIlder J, Patrick S, Hackney M, Lustberg M, Worthen-Chaudhari L. Case Study in Chemotherapy-Induced Neuropathy: Tango Dance Improved Over-Ground Local Gait Stability. Archives Of Physical Medicine And Rehabilitation 2023, 104: e16. DOI: 10.1016/j.apmr.2022.12.044.Peer-Reviewed Original ResearchChemotherapy-induced neuropathyGait stability indexBreast cancerGait stabilityTango danceDynamic gait stabilityOncology outpatientsBC survivorsSteady-state gaitGait assessmentClinical utilityNeuromechanical functionNeuropathyBalance deficitsInterventionFurther studiesHuman applicationSurvivorsMovement variabilityWeeksTest assessmentAssessmentOutpatientsCancerPerson's resistanceEffect of Partnered Dance Intervention on Upper Extremity Outcomes for Breast Cancer Survivors With CIPN
Bland C, Worthen-Chaudhari L, Hackney M, Lustberg M, Crasta J. Effect of Partnered Dance Intervention on Upper Extremity Outcomes for Breast Cancer Survivors With CIPN. Archives Of Physical Medicine And Rehabilitation 2023, 104: e24. DOI: 10.1016/j.apmr.2022.12.067.Peer-Reviewed Original ResearchBreast cancer survivorsHand grip strengthGrip strengthCancer survivorsUpper extremity outcomesChemotherapy-induced neuropathyUpper extremity functionSenior Fitness TestCase seriesExtremity functionOutpatient oncologyBreast cancerJamar dynamometerMAIN OUTCOMEDance interventionDance-based interventionBalance deficitsFitness testsT-testCIPNTango danceInterventionSurvivorsOutcomesNeuropathyGoal Attainment Scaling with a Dance-Based Intervention for Breast Cancer Survivors With CIPN: Pilot Study
Bland C, Worthen-Chaudhari L, Hackney M, Crasta J, Lustberg M. Goal Attainment Scaling with a Dance-Based Intervention for Breast Cancer Survivors With CIPN: Pilot Study. Archives Of Physical Medicine And Rehabilitation 2023, 104: e31-e32. DOI: 10.1016/j.apmr.2022.12.089.Peer-Reviewed Original ResearchChemotherapy-induced neuropathyBreast cancer survivorsGoal Attainment ScalingCancer survivorsIndividualized goalsClinical utilityT-scoreDance-based interventionPilot intervention studyLevel of functioningGAS T-scoresOverall T scoreOutpatient oncologyBreast cancerMAIN OUTCOMEPost interventionNeuropathyIntervention studiesLarger sample sizePaired-samples t-testPilot studyChange scoresSurvivorsInterventionFurther studies
2022
Patterns of Neuropathy in ALL Patients Treated with Vincristine Based Regimens with and without Tyrosine Kinase Inhibitors
Sigmund A, Fullmer M, Li R, Freeman T, Clemons B, Quimjian S, Haag H, Ni A, Hu S, Mims A, McNally G, Lustberg M, Bhatnagar B. Patterns of Neuropathy in ALL Patients Treated with Vincristine Based Regimens with and without Tyrosine Kinase Inhibitors. Blood 2022, 140: 5180-5182. DOI: 10.1182/blood-2022-166961.Peer-Reviewed Original Research
2021
SO-17 The global POLAR program: Top-line results of placebo-controlled studies of calmangafodipir on top of modified FOLFOX6 to prevent chemotherapy-induced peripheral neuropathy
Qvortrup C, Muro K, Lustberg M, Persson A, Näsström J, Carlsson S, Nagahama F, Pfeiffer P. SO-17 The global POLAR program: Top-line results of placebo-controlled studies of calmangafodipir on top of modified FOLFOX6 to prevent chemotherapy-induced peripheral neuropathy. Annals Of Oncology 2021, 32: s209-s210. DOI: 10.1016/j.annonc.2021.05.041.Peer-Reviewed Original ResearchPatient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN)
Hertz DL, Childs DS, Park SB, Faithfull S, Ke Y, Ali NT, McGlown SM, Chan A, Grech LB, Loprinzi CL, Ruddy KJ, Lustberg M. Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN). Cancer Treatment Reviews 2021, 99: 102241. PMID: 34174668, DOI: 10.1016/j.ctrv.2021.102241.Peer-Reviewed Original ResearchConceptsChemotherapy-induced peripheral neuropathyNeurotoxic chemotherapy treatmentTreatment alterationsCIPN severityPeripheral neuropathyPatient factorsChemotherapy treatmentRelative dose intensityClinical Oncology guidelinesNeurotoxic chemotherapyDose intensityProspective trialOncology guidelinesRetrospective analysisAdult cancersIndividual patientsInconsistent recommendationsPatientsTreatment efficacyClinical decisionSeverityNeuropathyAmerican SocietyTreatmentCliniciansEmerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
Li Y, Lustberg MB, Hu S. Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy. Cancers 2021, 13: 766. PMID: 33673136, PMCID: PMC7918689, DOI: 10.3390/cancers13040766.Peer-Reviewed Original ResearchChemotherapy-induced peripheral neuropathyPeripheral neuropathyPathogenesis of CIPNTreatment of CIPNFirst-line chemotherapeutic agentNon-pharmacological therapeuticsCommon adverse eventsNon-pharmacological strategiesQuality of lifeAdverse eventsClinical outcomesCancer survivorsEffective intervention strategiesClinical trialsSide effectsChemotherapeutic agentsEffective interventionsVinca alkaloidsNew targetsIntervention strategiesNeuropathyPrior failureClinical researchersPlatinum compoundsTherapeutics
2017
Effect of chemotherapy-induced peripheral neuropathy on postural control in cancer survivors.
Herman H, Monfort S, Pan X, Chaudhari A, Lustberg M. Effect of chemotherapy-induced peripheral neuropathy on postural control in cancer survivors. Journal Of Clinical Oncology 2017, 35: 128-128. DOI: 10.1200/jco.2017.35.5_suppl.128.Peer-Reviewed Original ResearchChemotherapy-induced peripheral neuropathySensory symptomsCancer patientsCIPN symptomsPeripheral neuropathyPostural controlCommon dose-limiting toxicityEORTC QLQ-CIPN20Patients' sensory symptomsDose-limiting toxicityPoor controlPost-treatment sequelaeRisk of fallsCourse of treatmentQuality of lifeQLQ-CIPN20Oxaliplatin chemotherapyCurative treatmentCancer survivorsCenter of pressureClose monitoringPatientsPoor balancePostural stabilityNeuropathy
2014
Management options for established chemotherapy-induced peripheral neuropathy
Pachman D, Watson J, Lustberg M, Wagner-Johnston N, Chan A, Broadfield L, Cheung Y, Steer C, Storey D, Chandwani K, Paice J, Jean-Pierre P, Oh J, Kamath J, Fallon M, Strik H, Koeppen S, Loprinzi C. Management options for established chemotherapy-induced peripheral neuropathy. Supportive Care In Cancer 2014, 22: 2281-2295. PMID: 24879391, DOI: 10.1007/s00520-014-2289-x.Peer-Reviewed Original ResearchConceptsChemotherapy-induced peripheral neuropathyPeripheral neuropathyTreatment of CIPNPeripheral neuropathy syndromesCancer treatment outcomesQuality of lifeClinical practice experienceCIPN treatmentNeuropathy syndromesTreatment optionsTreatment outcomesTherapeutic interventionsChemotherapeutic agentsPsychosocial functioningAvailable evidenceLimited evidenceNeuropathyPatientsTreatmentCliniciansAvailable literaturePractice experienceManagement optionsEvidenceOptions